Imricor Medical : Letter to Shareholders and Online Meeting Guide

ASX Announcement

7 April 2022

Dear fellow stockholders,

On behalf of the Board, I am pleased to invite you to attend Imricor's annual meeting of stockholders which, due to restrictions on travel and public gatherings associated with COVID-19, will be held as a virtual meeting. Details of this meeting are provided below:

Date:

Wednesday, 4 May 2022 at 9:00am Sydney time or Tuesday, 3 May 2022 at 6:00pm US Central Daylight Time

URL:

meetnow.global/MT5LJH

You will need the latest versions of Chrome, Safari, Edge or Firefox. Please ensure your browser is compatible.

Voting options

While the virtual meeting will include mechanisms by which to vote during the meeting1, I strongly encourage you to lodge your votes with our share and CDI registry provider, Computershare, prior to the meeting.

In the coming week, stockholders will receive a notice card in the mail, with instructions on how to access the proxy statement and accompanying Notice of Meeting. CDI holders will receive the proxy statement and accompanying Notice of Meeting along with a CDI Voting Instruction Form by post or email in accordance with communication preferences. This documentation will provide you with the information you need to lodge your votes with Computershare.

If you do not receive the above information, I encourage you to contact Computershare using the details provided below:

• • Stockholders: 1-866-641-4276

• • CDI holders: 1300 850 505 (within Australia) or [phone] outside Australia)

Voting deadlines

Stockholders may vote prior to the meeting over the internet or by telephone, following the instructions on the notice card that has been dispatched by Computershare. If this vote is submitted after 6:00 p.m., on May 3, 2022 your vote will be cast as if you were personally present at the meeting

CDI holders may vote online or by returning their CDI Voting Instruction Form to Computershare. Voting instructions must be received by Computershare no later than 9:00am Sydney time on Sunday, 1 May 2022 or 6:00pm US Central Daylight Time on Saturday, 30 April 2022.

Further information on voting is included in the accompanying proxy statement.

1 Note that if you are a CDI holder you may not vote online at the meeting unless you have nominated yourself to be appointed as CDN's proxy prior to the meeting.

Participating in the meeting

The Board welcomes stockholders and CDI holders to participate in Imricor's virtual meeting during which you will have the ability to ask questions online. There are a number of ways in which to participate and I therefore encourage you to familiarise yourself with the attached guide prior to joining the meeting.

For stockholders:

• 1. Log on to the meeting using the meeting ID meetnow.global/MT5LJH

• 2. Select 'I am a Shareholder/Guest'

• 3. Enter your username - Shareholder enter with a 15 digit control number/ Guests will enter with their Name/Email

For proxies (including a CDI holder who has appointed themselves as CDN's2 proxy):

• 1. Log on to the meeting using the meeting meetnow.global/MT5LJH

• 2. Select 'I am a Shareholder/Guest'

• 3. Request your unique invitation link by contacting Computershare on [phone] during the online registration period which will be open one hour prior to the meeting

Note that stockholders and CDI holders who wish to appoint a third-party proxy to attend the virtual meeting on their behalf must appoint this proxy prior to registering for online access to the meeting. Information on appointing a proxy is provided in the meeting information you will receive from Computershare.

For CDI holders (who have not appointed themselves or someone else as CDN's proxy):

• 1. Log on to the meeting using the meeting ID meetnow.global/MT5LJH

• 2. Select 'I am a CDI holder/Guest'

• 3. Enter your name and email address

Please note that should you lodge votes at the virtual meeting, these votes will replace those previously lodged with Computershare.

Further information on participating at the meeting is included in the proxy statement and in the virtual meeting guide.

An electronic version of Imricor's 2021 Annual Report is available on the ASX website.

I look forward to your participation at the AGM and thank you for your ongoing support of Imricor.

Yours sincerely,

Steve Wedan Chair

Authorised for release by Steve Wedan, Executive Chair, President, and CEO.

2 CHESS Depositary Nominees Pty Limited is the holder of record for all shares beneficially owned by holders of CDIs.

ENDS

Further Information

Investors:

Steve Wedan

Executive Chair, President and CEO Email:[e-mail]

Investors & Australian Media: Brett Ward

Senior Advisor, Cato & Clive Email:[e-mail] Mobile: [phone]

Rest of World Media: Nick Twohy

Vice President of Marketing, Imricor Email:[e-mail] Phone: [phone]

About Imricor

Investors (Australia):

Aisha Jabeen Advisor, Cato & Clive

Email:[e-mail] Phone: [phone]

Imricor Medical Systems, Inc. (ASX:IMR) is a leading developer of innovative MRI-compatible medical devices which can be used to carry out MRI-guided cardiac catheter ablation procedures. Headquartered in the US, Imricor seeks to make a meaningful impact on patients, healthcare professionals, and healthcare facilities around the world by increasing the success rates and bringing down the overall costs of cardiac catheter ablation procedures.

Imricor's Products

Imricor is a pioneer and leader in developing MRI-compatible products for cardiac catheter ablation procedures, and believes it is the first company in the world to bring commercially viable and safe MRI-compatible products to the cardiac catheter ablation market.

The Vision-MR Ablation Catheter is the Company's prime product offering, specifically designed to work under real-time MRI guidance, with the intent of enabling higher success rates along with a faster and safer treatment compared to conventional procedures using x-ray guided catheters. The Vision-MR Ablation Catheter has been approved in the European Union with an indication for treating type 1 atrial flutter. Imricor intends to seek approval for expanded indications in the future. The Company is also in the early stages of pursuing the required regulatory approvals to place its key products on the market in Australia and the U.S.

The Company has also obtained approval within the EU for the sale of the Advantage-MR EP Recorder/Stimulator System and its consumable product, the Vision-MR Dispersive Electrode.

Imricor sells its capital and consumable products to hospitals and clinics for use in Interventional Cardiac Magnetic Resonance Imaging (iCMR) labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed. An iCMR lab is an interventional lab that is fitted with MRI equipment for use in cardiac diagnostic and interventional procedures. The installation of iCMR labs is driven primarily by MRI equipment vendors working collaboratively with Imricor. Vendors such as Koninklijke Philips N.V. and Siemens Healthcare GmbH help to target certain sites and support the design and construction of iCMR labs for those sites.

Foreign Ownership Restrictions

400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400

| imricor.com

Imricor's CHESS Depositary Interests (CDIs) are issued in reliance on the exemption from registration contained in Regulation S of the US Securities Act of 1933 (Securities Act) for offers which are made outside the US. Accordingly, the CDIs have not been, and will not be, registered under the Securities Act or the laws of any state or other jurisdiction in the US. As a result of relying on the Regulation S exemption, the CDIs are 'restricted securities' under Rule 144 of the Securities Act. This means that you are unable to sell the CDIs into the US or to a US person for the foreseeable future except in very limited circumstances after the expiration of a restricted period, unless the re-sale of the CDIs is registered under the Securities Act or an exemption is available. To enforce the above transfer restrictions, all CDIs issued bear a 'FOR US' designation on the Australian Securities Exchange (ASX). This designation restricts any CDIs from being sold on ASX to US persons. However, you are still able to freely transfer your CDIs on ASX to any person other than a US person. In addition, hedging transactions with regard to the CDIs may only be conducted in accordance with the Securities Act.

Forward-Looking Statements

This announcement contains or may contain forward-looking statements that are based on the Company's management's beliefs, assumptions and expectations and on information currently available to management. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These include, without limitation, EU commercial market acceptance and EU. sales of our product as well as our expectations with respect to our ability to develop and commercialise new products. Management believes that these forward-looking statements are reasonable when made. You should not place undue reliance on forward-looking statements because they speak only as of the date when made. Imricor does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Imricor may not actually achieve the plans, projections or expectations disclosed in forward-looking statements. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.

ONLINE MEETING GUIDE

GETTING STARTED

If you choose to participate online you will be able to view a live webcast of the meeting, ask the Directors questions online and submit your votes in real time. To participate online visithttps://meetnow.global/au on your smartphone, tablet or computer. You will need the latest versions of Chrome, Safari, Edge or Firefox. Please ensure your browser is compatible.

TO LOG IN, YOU MUST HAVE THE FOLLOWING INFORMATION:

Australian Residents

Overseas Residents

Appointed Proxies

SRN or HIN and postcode of your registered address.

SRN or HIN and country of your registered address.

Please contact Computershare Investor Services on [phone] to request your unique email invitation link prior to the meeting day.

PARTICIPATING AT THE MEETING

To participate in the online meeting,visithttps://meetnow.global/au. Then enter the company name in the 'Filter' field. Select and click on the displayed meeting.

To register as a shareholder Select 'Shareholder', enter your SRN or HIN and select your country. If Australia, also enter your post code.

or To register as a proxyholder

To access the meeting click

on the link in the invitation

e-mail sent to you. Or select

or To register as a guest

Select 'Guest' and enter

your details.

the e-mail.

'Invitation' and enter your

invite code provided in

278060_09_V2

1